Pierre B. Johansen
Novo Nordisk Park
Malov, Denmark
Malov, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Systemic inflammation is associated with increased risk of death in population with atherosclerotic cardiovascular disease and chronic kidney disease-a Danish national register study.
Journal: Frontiers in cardiovascular medicine
Published: November 19, 2025
Impact of systemic inflammation on healthcare resource utilization and cost in patients with atherosclerotic cardiovascular disease and chronic kidney disease.
Journal: Journal of medical economics
Published: August 04, 2025
Systemic inflammation prevalence in patients with atherosclerotic cardiovascular disease and chronic kidney disease: a population-based study using a nationwide primary care database in Spain.
Journal: Frontiers in cardiovascular medicine
Published: December 02, 2024
The substantial costs to society associated with obesity - a Danish register-based study based on 2002-2018 data.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 17, 2022
The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review.
Journal: PharmacoEconomics
Published: March 10, 2022
The prevalence of comorbidities in Danish patients with obesity - A Danish register-based study based on data from 2002 to 2018.
Journal: Clinical obesity
Published: December 03, 2021
The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies.
Journal: Gastro hep advances
Published: November 25, 2021
The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.
Journal: JHEP reports : innovation in hepatology
Published: November 25, 2021
The Effect of Bariatric Surgery on Healthcare Costs and Labor Market Attachment.
Journal: Obesity surgery
Published: November 02, 2021
A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease.
Journal: Endocrinology, diabetes & metabolism
Published: February 25, 2021
Authors' reply to Comment on "External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions".
Journal: PharmacoEconomics
Published: November 10, 2020
Last Updated: 09/26/2026